Literature DB >> 28035590

Author's Reply to Proost: "Challenges in Individualizing Drug Dosage for Intensive Care Unit Patients".

Roger W Jelliffe1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28035590     DOI: 10.1007/s40262-016-0482-4

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  8 in total

1.  A Bayesian approach to tracking patients having changing pharmacokinetic parameters.

Authors:  David S Bayard; Roger W Jelliffe
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-02       Impact factor: 2.745

2.  Evaluation and comparison of simple multiple model, richer data multiple model, and sequential interacting multiple model (IMM) Bayesian analyses of gentamicin and vancomycin data collected from patients undergoing cardiothoracic surgery.

Authors:  Iona Macdonald; Christine E Staatz; Roger W Jelliffe; Alison H Thomson
Journal:  Ther Drug Monit       Date:  2008-02       Impact factor: 3.681

3.  Challenges in Individualizing Drug Dosage for Intensive Care Unit Patients: Is Augmented Renal Clearance What We Really Want to Know? Some Suggested Management Approaches and Clinical Software Tools.

Authors:  Roger Jelliffe
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

4.  Optimal methodology is important for optimal pharmacokinetic studies, therapeutic drug monitoring and patient care.

Authors:  Roger Jelliffe
Journal:  Clin Pharmacokinet       Date:  2015-09       Impact factor: 6.447

5.  Comment on: "Challenges in Individualizing Drug Dosage for Intensive Care Unit Patients: Is Augmented Renal Clearance What We Really Want to Know? Some Suggested Management Approaches and Clinical Software Tools".

Authors:  Johannes H Proost
Journal:  Clin Pharmacokinet       Date:  2017-03       Impact factor: 6.447

6.  Clearance concepts in pharmacokinetics.

Authors:  M Rowland; L Z Benet; G G Graham
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

7.  Optimal sampling times for pharmacokinetic experiments.

Authors:  D Z D'Argenio
Journal:  J Pharmacokinet Biopharm       Date:  1981-12

8.  Estimation of creatinine clearance in patients with unstable renal function, without a urine specimen.

Authors:  Roger Jelliffe
Journal:  Am J Nephrol       Date:  2002 Jul-Aug       Impact factor: 3.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.